BlackRock, Inc. 13D and 13G filings for Immuneering Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-05 12:21 pm Sale |
2024-03-31 | 13G | Immuneering Corporation IMRX |
BLACKROCK INC BLK |
1,377,120 4.700% |
-720,286 (-34.34%) |
Filing |
| 2024-01-26 4:23 pm Purchase |
2023-12-31 | 13G | Immuneering Corporation IMRX |
BLACKROCK INC BLK |
2,097,406 7.200% |
760,970 (+56.94%) |
Filing |
| 2023-05-05 11:52 am Sale |
2023-04-30 | 13G | Immuneering Corporation IMRX |
BLACKROCK INC BLK |
1,336,436 4.600% |
-11,948 (-0.89%) |
Filing |
| 2023-02-01 4:54 pm Sale |
2022-12-31 | 13G | Immuneering Corporation IMRX |
BLACKROCK INC BLK |
1,348,384 5.100% |
-367,786 (-21.43%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Immuneering Corporation IMRX |
BLACKROCK INC BLK |
1,716,170 6.600% |
1,716,170 (New Position) |
Filing |